All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Ongoing | 2016-000097-38 | Randomized, double-blind, placebo-controlled study to measure 2L®ALERG (homeopathic drug) efficacy on symptoms of allergic rhinitis and allergic rhinoconjunctivitis in patients with a seasonal allergy... | not-yet-due | |
Other | 2019-001085-15 | Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LHERP® in patients with recurrent orofacial herpes infections. Étude randomisée, contrôlée contre placebo, en double ... | not-yet-due | |
Other | 2019-001443-52 | Randomized study to evaluate 2LVERU® JUNIOR and 2LVERU® efficacy on the treatment of warts. Protocol EVAsION Etude randomisée pour évaluer l’efficacité du 2LVERU® JUNIOR et du 2LVERU® sur le traite... | not-yet-due | |
Not reported Terminated | 2019-001572-11 | Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LHERP® in patients with recurrent genital herpes infections. Étude randomisée, contrôlée contre placebo, en double av... | 2023-04-18 | due-trials |
Other | 2020-000085-42 | Randomized, placebo-controlled, double blind study to evaluate the efficacy of 2LEBV® and 2LXFS® on asthenia in patients with an EBV infection. EBVAST Study | not-yet-due |